---
figid: PMC4991353__nihms-810145-f0002
figtitle: Canonical and non-canonical Wnt pathways have differing effects in cancer
organisms:
- Homo sapiens
- Mus musculus
- Sesamum indicum
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC4991353
filename: nihms-810145-f0002.jpg
figlink: /pmc/articles/PMC4991353/figure/F2/
number: F2
caption: The canonical and non-canonical Wnt pathways have differing effects in cancer.
  A, Wnt1/3 binds the G-protein coupled receptor Fzd and the tyrosine kinase receptors
  LRP5/6 to initiate signaling through the canonical signaling pathway. The resulting
  signaling complex promotes β-catenin translocation to the nucleus and thus drives
  the radial growth phase of melanoma, whereby cells differentiate and proliferate
  on the dermis. B, An increase in Wnt5a activates the non-canonical Wnt signaling
  pathway through Fzd and the tyrosine kinase ROR2. Downstream effectors such as Arf6,
  Akt, Jnk and PKC drive a transition to the vertical growth phase, whereby melanoma
  invade through the dermis and metastasize. C, Conversely, in breast cancer cells,
  Wnt5a signaling though the non-canonical pathway activates CAMKII to facilitate
  β-catenin degradation, preventing the transcription of genes that promote metastasis
  and invasion.
papertitle: The heterogeneity of store-operated calcium entry in melanoma.
reftext: Robert Hooper, et al. Sci China Life Sci. 2016 Aug;59(8):764-769.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9104807
figid_alias: PMC4991353__F2
figtype: Figure
redirect_from: /figures/PMC4991353__F2
ndex: 84935f58-df11-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4991353__nihms-810145-f0002.html
  '@type': Dataset
  description: The canonical and non-canonical Wnt pathways have differing effects
    in cancer. A, Wnt1/3 binds the G-protein coupled receptor Fzd and the tyrosine
    kinase receptors LRP5/6 to initiate signaling through the canonical signaling
    pathway. The resulting signaling complex promotes β-catenin translocation to the
    nucleus and thus drives the radial growth phase of melanoma, whereby cells differentiate
    and proliferate on the dermis. B, An increase in Wnt5a activates the non-canonical
    Wnt signaling pathway through Fzd and the tyrosine kinase ROR2. Downstream effectors
    such as Arf6, Akt, Jnk and PKC drive a transition to the vertical growth phase,
    whereby melanoma invade through the dermis and metastasize. C, Conversely, in
    breast cancer cells, Wnt5a signaling though the non-canonical pathway activates
    CAMKII to facilitate β-catenin degradation, preventing the transcription of genes
    that promote metastasis and invasion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wnt5a
  - Wnt3a
  - Wnt1
  - Apc
  - Axin1
  - Shh
  - Ctnnb1
  - Camk2a
  - Camk2b
  - Arf6
  - Mapk8
  - Pik3r1
  - Akt1
  - Lrp6
  - Lrp5
  - Ror2
  - Rora
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - ADAR
  - DVL1P1
  - CTNNB1
  - CAMK2G
  - ARF6
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - LRP6
  - LRP5
  - ROR2
  - RORA
  - wnt5a
  - wnt3a
  - wnt1
  - apc
  - ctnnb1
  - arf6a
  - mapk8b
  - lrp6
  - lrp5
  - ror2
  - Cancer
---
